Rakuten Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17M Buy
11,746
+949
+9% +$290K 0.01% 316
2026
Q1
$2.65M Buy
10,797
+1,221
+13% +$304K 0.01% 353
2025
Q4
$2.64M Sell
9,576
-84,493
-90% -$23.1M 0.01% 401
2025
Q3
$905K Buy
+94,069
New +$22.9M ﹤0.01% 488
2025
Q1
$1.51M Buy
+6,812
New +$1.88M 0.01% 435

Other funds holding WST

Rakuten Investment Management's WST Position: Q2 2026 in Review

Rakuten Investment Management increased its West Pharmaceutical (WST) stake by 8.8% in Q2 2026, buying an estimated $290K and bringing the position to 11,746 shares worth $4.17M. The position accounts for 0.01% of the portfolio, ranked #316.

Rakuten Investment Management first reported a position in WST in Q1 2025 and has held it in 5 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Rakuten Investment Management held 11,746 shares of West Pharmaceutical worth $4.17M as of Q2 2026.
  • Rakuten Investment Management bought 949 West Pharmaceutical shares in Q2 2026, an estimated $290K.
  • West Pharmaceutical made up 0.01% of Rakuten Investment Management's portfolio in Q2 2026, its #316 holding.
  • Rakuten Investment Management first reported a position in West Pharmaceutical in Q1 2025 and has held it in 5 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.